Paper13620740
Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.
HAZARD JB and 2 others. J Clin Endocrinol Metab, 1959. Cited by 724 papers, by iCite.
Cite this record
ConductScience Library. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. Papers, record 13620740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/13620740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Medulla | Major topic |
| Carcinoma | Major topic |
| Neoplasms | Major topic |
| Thyroid Gland | Major topic |
| Thyroid Neoplasms | Major topic |
| Humans |
Source PubMed
Cited by147
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 724 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41374422 | Amyloid A Amyloidosis Secondary to Thymoma. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41374422 | PubMed |
| 40853492 | Clinical prognostic risk assessment of different pathological subtypes of papillary thyroid cancer: a systematic review and network meta-analysis. | Langenbecks Arch Surg | 2025 | https://conductscience.org/library/papers/40853492 | PubMed |
| 40715712 | Geospatial inheritance across the breath of the RET mutational landscape of multiple endocrine neoplasia 2A. | Endocrine | 2025 | https://conductscience.org/library/papers/40715712 | PubMed |
| 40464083 | Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two-Step Approach. | Clin Endocrinol (Oxf) | 2025 | https://conductscience.org/library/papers/40464083 | PubMed |
| 40340909 | MEN2: surgical precision in the era of precision medicine. | Endocr Relat Cancer | 2025 | https://conductscience.org/library/papers/40340909 | PubMed |
| 40102261 | Surgical Treatment of Medullary Thyroid Cancer. | Recent Results Cancer Res | 2025 | https://conductscience.org/library/papers/40102261 | PubMed |
| 40102255 | Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma. | Recent Results Cancer Res | 2025 | https://conductscience.org/library/papers/40102255 | PubMed |
| 40102254 | Thyroid C-Cell Biology and Oncogenic Transformation. | Recent Results Cancer Res | 2025 | https://conductscience.org/library/papers/40102254 | PubMed |
| 40102253 | Histopathology of C Cells and Medullary Thyroid Carcinoma. | Recent Results Cancer Res | 2025 | https://conductscience.org/library/papers/40102253 | PubMed |
| 40075585 | Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075585 | PubMed |
| 39009923 | Treatment and management of medullary thyroid microcarcinoma: a 10-year retrospective study from a single center. | Endocrine | 2024 | https://conductscience.org/library/papers/39009923 | PubMed |
| 38806713 | [30 years of prophylactic thyroidectomy for hereditary medullary thyroid cancer : A milestone in translational medicine]. | Chirurgie (Heidelb) | 2024 | https://conductscience.org/library/papers/38806713 | PubMed |
| 38745826 | Medullary Thyroid Cancer: Epidemiology and Characteristics According to Data From the Marne-Ardennes Register 1975-2018. | J Endocr Soc | 2024 | https://conductscience.org/library/papers/38745826 | PubMed |
| 38010402 | International medullary thyroid carcinoma grading system: an Indian tertiary care centre experience. | Eur Arch Otorhinolaryngol | 2024 | https://conductscience.org/library/papers/38010402 | PubMed |
| 37835559 | Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835559 | PubMed |
| 37715050 | Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities. | Rev Endocr Metab Disord | 2024 | https://conductscience.org/library/papers/37715050 | PubMed |
| 37511745 | Personalized Medicine in Medullary Thyroid Carcinoma: A Broad Review of Emerging Treatments. | J Pers Med | 2023 | https://conductscience.org/library/papers/37511745 | PubMed |
| 37270155 | Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience. | Mod Pathol | 2023 | https://conductscience.org/library/papers/37270155 | PubMed |
| 36672624 | Clinicopathological Profile of Medullary Thyroid Carcinoma-Could We Predict Aggressive Behavior? | Biomedicines | 2023 | https://conductscience.org/library/papers/36672624 | PubMed |
| 36600874 | Case Report: A Challenging Clinical Problem of Calcitonin-Negative Medullary Thyroid Cancer Diagnosis and Surveillance. | Cureus | 2022 | https://conductscience.org/library/papers/36600874 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/13620740
GET https://conductscience.org/api/papers/v1/13620740/cited_by?page=2